Nurix therapeutics to participate in upcoming investor conferences

San francisco, aug. 31, 2022 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), a biopharmaceutical company developing targeted protein modulation drugs, today announced that arthur t. sands, m.d., ph.d., nurix's president and chief executive officer, will participate in the following conferences in september:
NRIX Ratings Summary
NRIX Quant Ranking